Close Menu

NEW YORK (GenomeWeb) – Guardant Health and Flatiron Health have announced a collaboration to integrate Guardant Health's liquid biopsy genomic testing results with clinical treatment and outcomes data using Flatiron's cloud-based information platform. 

The partners said this new ability to link patients' genomic data with their clinical records will hopefully support the accelerated development of targeted therapies for cancer by enabling life science companies to more quickly recruit and select patients for trials and to more easily follow subjects and their progress over time.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.